https://www.selleckchem.com/pr....oducts/crenolanib-cp
Deterioration in dynamic balance-based features was only noted in pwMS with a moderate and severe disability. A conceptual model of gait for disease-specific mobility assessment in pwMS was successfully developed and tested. The new model, built with metrics that represent gait impairment in pwMS, highlighted clinically relevant changes across different disability levels, including those with no clinically observable walking disability. This shows the clear potential as a monitoring biomarker in pwMS. The new model, built w